These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 22008772
41. Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure'. Chiang CY, Van Deun A, Trébucq A, Heldal E, Caminero JA, Aït-Khaled N. Int J Tuberc Lung Dis; 2011 Jan; 15(1):4-5. PubMed ID: 21276289 [No Abstract] [Full Text] [Related]
42. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA. Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [Abstract] [Full Text] [Related]
47. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Padayatchi N, Bamber S, Dawood H, Bobat R. Pediatr Infect Dis J; 2006 Feb; 25(2):147-50. PubMed ID: 16462292 [Abstract] [Full Text] [Related]
48. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru. Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC. Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737 [Abstract] [Full Text] [Related]
50. Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia. Mekonen M, Abate E, Aseffa A, Anagaw B, Elias D, Hailu E, Idh J, Moges F, Wolde-Amanuel Y, Asrat D, Yamuah L, Britton S, Stendahl O, Schön T. Ethiop Med J; 2010 Jul; 48(3):203-10. PubMed ID: 21073081 [Abstract] [Full Text] [Related]
51. Advanced multifocal tuberculous spondylitis without disk involvement and with multidrug-resistant bacilli. Neher A, Kopp W, Berna G, Frank J, Kohlhäufl M. Clin Infect Dis; 2007 Oct 15; 45(8):e109-12. PubMed ID: 17879905 [Abstract] [Full Text] [Related]
52. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases. Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA. Am J Ther; 2011 Sep 15; 18(5):343-9. PubMed ID: 20535008 [Abstract] [Full Text] [Related]
58. Sputum smear microscopy result: a predictor for drug-resistant tuberculosis? Dean AS, Zignol M, Lumb R, Lalor M, Skrahina A, Floyd K. Int J Tuberc Lung Dis; 2016 Jul 15; 20(7):864-5. PubMed ID: 27287635 [Abstract] [Full Text] [Related]
59. Spot or early morning sample for mycobacterial culture: which? Das D, Dwibedi B, Kar SK. Int J Tuberc Lung Dis; 2014 Mar 15; 18(3):310-1. PubMed ID: 24670567 [Abstract] [Full Text] [Related]